Use access key #2 to skip to page content.
$11.00 -0.10 (-0.90%)
5/16/2008 4:01 PM

AMERICAN ORIENTL BIO (AOB)

CAPS Rating:
****

The Company, together with its wholly owned subsidiaries, is a pharmaceutical and Traditional Chinese Medicine company which develops, manufactures and commercializes both plant-based pharmaceutical and plant-based nutraceutical products.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other players to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating AOB

Add Stock to Watchlist

What the Community Thinks Add a widget featuring this stock to your blog!

Total Players

1336 Outperforms
50 Underperforms
 

All-Stars

389 Outperforms
20 Underperforms
 

Wall Street

4 Outperforms
1 Underperforms
 

Players bullish on AOB are also bullish on:

Players bearish on AOB are also bearish on:

Ticker Tags

Drug Manufacturers - Major (27), Small Cap (1922), Nutraceuticals (1), China (142), Biotechnology (291)
Suggest a tag

AMERICAN ORIENTL BIO At A Glance

Current Price: $11.00
Last Trade Time: 5/16/2008 4:01 PM
Open: $11.23
Previous Close: $11.10
Daily Range: $10.85 - $11.23
52-Week Range: $6.83 - $14.48
Volume: 1,839,354
Market Cap: $868.28M
P/E Ratio: 17.34
Compare Our Special Broker Offers!

Stock Trends

AOB VS S&P 500 (SPY)

AOB 12 month chart vs. S&P

News & Discussion Boards

Other News Headlines for AOB

More Headlines...

Top Bull Pitch

Recs

12

AMERICAN ORIENTL BIO (AOB)

Avatar daisytheblacklab (88.71) Submitted: 8/24/07 4:06 AM

My father-in-law runs a much smaller but quite successful business in the same niche, but exports mostly to S. Korea (herbal supplements and remedies, etc.). Fact is, Asians love buying anything that someone says is good for their health, whether it's true or not. And there's no way traditional Ch...More

Replies: 0 | Reply | Permalink

Top Bear Pitch

Recs

8

AMERICAN ORIENTL BIO (AOB)

Avatar KenN513 (98.88) Submitted: 7/19/07 9:34 AM

As Longhorn Leghorn used to say "snake, I say, snake oil!" This company has great numbers on paper. A very close examination of the company itself begins to smell bad. Before you rate this company positive, please click on the link fellow Fool prospectorgadget has provided.

Replies: 9 | Reply | Permalink

CAPS Players

picks per page. CHANGE

Results 1 - 5 of 220 :   1 2 3 4 5 Next » Jump to page:

Recs

0

 (AOB)

Avatar adrahn12 (< 20) Submitted: 5/16/08 3:28 PM : Outperform Start Price: $11.00 AOB Score: 0.06

I can see some of their products in healh food stores in the US eventually too! Example: SoyPeptide Beverage

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (AOB)

Avatar handoverhill (< 20) Submitted: 5/14/08 6:44 AM : Outperform Start Price: $12.12 AOB Score: -10.42

This stock is on the upside according to the charts and this is one of the healthcare sector stocks and is in the Biotechnology and drugs industry. It is given the thumbs up sign according to the teach me to trade group. It's revenue for the end of December 2007 was increased 46% and the net income increased 48% which reflects increased sales of PBP products due to higher Shuanglian injection power and cease enuresis soft gel sales and higher income from otc product sales.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (AOB)

Avatar tuffsledding (99.94) Submitted: 5/13/08 10:47 PM : Outperform Start Price: $12.12 AOB Score: -10.42

Expect volatility, but if Chinese pharmaceutical usage begins to rise from its current very low level (compared to western countries), this company will reap huge benefits. With the growth of Chinese economy, rapid increase in disposable income and the desire to adopt western ways, this could be a rocket (or a dud, if the naysayers are correct). Not for the faint of heart, but a worthwhile gamble here in CAPS.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (AOB)

Avatar imobillc (69.51) Submitted: 5/12/08 5:33 PM : Outperform Start Price: $11.22 AOB Score: -4.27

Neutral position! 52Wk Low: $6.83    Good for CAPS points....
- American Oriental Bioengineering, Inc. (AOBO) is a fully integrated, pharmaceutical company engaged in the development, manufacture and commercialization of a range of pharmaceutical and healthcare products. A majority of its products are offered and derived from Chinese based traditional medicines and are manufactured using plant based materials. Its diversified business consists of prescription pharmaceutical products, over-the-counter (OTC) pharmaceutical products and nutraceutical products. Its pharmaceutical products have been approved by the Chinese State Food and Drug Administration (SFDA), based on demonstrated safety and efficacy. It sells its products primarily to hospitals, clinics, pharmacies and retail outlets at over 100,000 locations in all provinces, including rural areas and major cities in China. In October 2007, it completed the acquisition of Guangxi Boke Pharmaceutical Company Limited.

The Company's pharmaceutical products are modernized versions of Traditional Chinese Medicine (TCM). It markets over 40 pharmaceutical products in China. Its two prescription pharmaceutical products marketed in China include Shuanghuanglian Lyophilized Injection Powder (SHL Injection Powder) and Cease Enuresis Soft Gel (CE Gel). SHL Injection Power is an anti-viral injection effective in treating respiratory infections, bronchitis and tonsillitis, and CE Gel is indicated to alleviate bedwetting. It markets its SHL Injection Powder through its brand name SHJ, and its CE Gel through Harbin Three Happiness Bioengineering Co., Ltd (Three Happiness).

The Company markets several nutraceutical products as general nutritional supplements in China, including its soybean peptide based drinks, tablets, powder and instant coffee. In addition to its marketed products, it has a portfolio of over 400 prescription and OTC pharmaceutical products. The Company's pharmaceutical products include Cease Enuresis Patch, Jinji Capsule and Jinji Yimucao. Its nutraceutical products include Soy Peptide Series.

The Company competes with Harbin Pharmaceutical Group, Shangdong Zhiling Pharmaceutical Company, Tianjin Zhongxin Company, Shanxi Dingxing Healthcare Scientific Limited, Jilin Tianguang Pharmaceutical Limited, Huahong Pharmaceutical Group, Qianjin Pharmaceutical Group, Guangdong Foshan Dezhong Pharmaceutical Co., Ltd, Wuhan Zhonglian Pharmaceutical Co., Ltd, Guangzhou Qixing Pharmaceutical Co., Ltd, Leneng Bioengineering Company, Harbin High-Tech Company Limited.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (AOB)

Avatar kryeakey (38.40) Submitted: 5/11/08 9:50 AM : Outperform Start Price: $11.79 AOB Score: -9.15

Fast growing natural medicine stores in China. 42% grwoth to target price. Beat estimates.

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 5 of 220 :   1 2 3 4 5 Next » Jump to page:

Wall Street

Results 1 - 5 of 5  

picks per page. CHANGE Expand All Pitches

Top
Pick
Player NamePlayer RatingStart
Date
CallTime FrameStart
Price
Stock
Gain
S&P
Gain
ScorePitch
TrackJefferies 89.06 11/21/07 Outperform NS $10.65+3.29%-0.29%+3.58
TrackZacks 93.00 10/22/07 Outperform 3M $12.53-12.21%-5.23%-6.98 Toggle the visibility of 60-Second Pitch and replies
TrackLazardCapit < 20 07/09/07 Outperform NS $9.70+13.40%-6.91%+20.31
TrackPiperJaff 68.94 07/09/07 Outperform NS $9.66+13.87%-6.86%+20.73
TrackBreanMurray 88.12 10/30/06 Outperform NS $7.04+56.25%+3.67%+52.58
TrackJimCramer 80.65 06/06/06 Underperform 3W $5.52+99.28%+12.27%-87.01

Results 1 - 5 of 5  

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners